News
- Author:
- Miriam E. Tucker
Publish date: January 17, 2020
The approval was based on data from the SUSTAIN 6 in patients with type 2 diabetes and established heart disease.
News
- Author:
- Miriam E. Tucker
Publish date: December 30, 2019
BUSAN, SOUTH KOREA – Results for older patients were similar to those for younger patients.
News
- Author:
- Miriam E. Tucker
Publish date: December 23, 2019
BUSAN, SOUTH KOREA – With many patients going online for information about diabetes, it is important they know which resources are most reliable.
News
- Author:
- Miriam E. Tucker
Publish date: December 12, 2019
BUSAN, SOUTH KOREA – Two experts came to different conclusions on this question during a heated, but jovial, debate last week at the International ...
News
- Author:
- Miriam E. Tucker
Publish date: December 7, 2019
BUSAN, SOUTH KOREA – Benefits are not clear, but risks are, says one expert; less stringency for high-risk adults does not always mean broader allo...
News
- Author:
- Miriam E. Tucker
Publish date: December 4, 2019
BUSAN, SOUTH KOREA – “The take-home point is that insulin rationing and blood glucose testing rationing is a reality for far more people with diabe...
News
- Author:
- Miriam E. Tucker
Publish date: September 10, 2012
Major Finding: By the end of the follow-up period, 9% (77) of the delayed group vs. 6% (57) of the immediate group experienced at least one primar...
News
- Author:
- Miriam E. Tucker
Publish date: September 7, 2012
Major Finding: Median overall survival – the primary end point – was 12.6 months for the pemetrexed regimen and 13.4 months for the pa...
News
- Author:
- Miriam E. Tucker
Publish date: September 7, 2012
Major Finding: There were no significant differences between prophylactic cranial irradiation and observation in the 5-year rates of survival (26....
News
- Author:
- Miriam E. Tucker
Publish date: September 6, 2012
Major Finding: When stage I NSCLC was treated with radiation alone, median survival improved significantly, from 16 months during 1999-2003 to 21 ...
News
- Author:
- Miriam E. Tucker
Publish date: August 30, 2012
Major Finding: The adjusted risk of heart failure (HF) and/or cardiomyopathy increased fourfold among women who received trastuzumab alone and sev...
News
- Author:
- Miriam E. Tucker
Publish date: August 30, 2012
Major Finding: At both 52 and 104 weeks, the rheumatoid arthritis patients receiving adalimumab plus methotrexate combination therapy had greater ...
News
- Author:
- Miriam E. Tucker
Publish date: August 22, 2012
Major Finding: During follow-up, type 2 diabetes developed in 110 of the bariatric surgery patients and in 392 controls, corresponding to incidenc...
News
- Author:
- Miriam E. Tucker
Publish date: August 22, 2012
News
- Author:
- Miriam E. Tucker
Publish date: August 21, 2012
Major Finding: At 1 year, the primary end point of major adverse cardiac events occurred in 4.3% of patients who received biolimus-eluting stents ...
